Overview
Hereditary persistence of alpha-fetoprotein (HPAFP) is a rare, benign genetic condition characterized by persistently elevated levels of alpha-fetoprotein (AFP) in the blood throughout life. Alpha-fetoprotein is a protein normally produced in large quantities by the fetal liver during development, with levels typically declining rapidly after birth to very low concentrations in healthy adults. In individuals with HPAFP, AFP levels remain abnormally elevated without any associated disease or clinical symptoms. This condition is clinically significant primarily because elevated AFP levels in adults are commonly used as a tumor marker, particularly for hepatocellular carcinoma (liver cancer), certain germ cell tumors, and other malignancies. Individuals with HPAFP may therefore be subjected to unnecessary and invasive diagnostic investigations if their hereditary condition is not recognized. The condition does not affect any organ system and is not associated with any pathological consequences — it is considered entirely benign. No treatment is required for hereditary persistence of alpha-fetoprotein, as it causes no symptoms or health problems. The primary clinical importance lies in awareness and correct diagnosis to avoid unnecessary cancer workups in affected individuals and their family members. Genetic counseling may be helpful to inform families about the benign nature of the condition. The condition has been linked to mutations affecting the AFP gene regulatory region on chromosome 4q.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Treatments
No FDA-approved treatments are currently listed for Hereditary persistence of alpha-fetoprotein.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary persistence of alpha-fetoprotein at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hereditary persistence of alpha-fetoprotein.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary persistence of alpha-fetoprotein.
Community
No community posts yet. Be the first to share your experience with Hereditary persistence of alpha-fetoprotein.
Start the conversation →Latest news about Hereditary persistence of alpha-fetoprotein
No recent news articles for Hereditary persistence of alpha-fetoprotein.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary persistence of alpha-fetoprotein
What is Hereditary persistence of alpha-fetoprotein?
Hereditary persistence of alpha-fetoprotein (HPAFP) is a rare, benign genetic condition characterized by persistently elevated levels of alpha-fetoprotein (AFP) in the blood throughout life. Alpha-fetoprotein is a protein normally produced in large quantities by the fetal liver during development, with levels typically declining rapidly after birth to very low concentrations in healthy adults. In individuals with HPAFP, AFP levels remain abnormally elevated without any associated disease or clinical symptoms. This condition is clinically significant primarily because elevated AFP levels in ad
How is Hereditary persistence of alpha-fetoprotein inherited?
Hereditary persistence of alpha-fetoprotein follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.